citalopram

1
Reactions 1404 - 2 Jun 2012 S Citalopram Syndrome of inappropriate antidiuretic hormone secretion treated with tolvaptan in an elderly patient: case report A 72-year-old man developed syndrome of inappropriate antidiuretic hormone secretion (SIADH) while receiving citalopram for depressive syndrome; he was successfully treated with tolvaptan. The man presented due to a fall followed by a convulsive episode with tonic-clonic seizures lasting 10 minutes. His family reported that he had been unstable when walking, irritable, disorientated and emotionally labile during the last 15 days. He had a history of frontal dementia, and depressive syndrome in the third week of treatment with citalopram [dosage and route not stated]. Based on sodium levels, and plasma and urine osmolarity findings, SIADH was diagnosed. Citalopram, suspected as the causative agent, was withdrawn. The man’s symptoms and hyponatraemia persisted despite water restriction and a hypertonic sodium chloride infusion was started. Attempts to withdraw the infusion over 3 weeks failed and tolvaptan 15 mg/day was introduced, with normalisation of his sodium levels. Treatment was withdrawn and he remained asymptomatic and normonatraemic 4 months after discharge. Pinal-Fernandez I, et al. Tolvaptan in antidiuretic hormone secretion syndrome secondary to treatment with citalopram. Revista Clinica Espanola 211: 491-2, No. 9, Oct 2011 [Spanish; summarised from a translation] - Spain 803071344 1 Reactions 2 Jun 2012 No. 1404 0114-9954/10/1404-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: nguyenkhue

Post on 19-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 1404 - 2 Jun 2012

SCitalopram

Syndrome of inappropriate antidiuretic hormonesecretion treated with tolvaptan in an elderlypatient: case report

A 72-year-old man developed syndrome of inappropriateantidiuretic hormone secretion (SIADH) while receivingcitalopram for depressive syndrome; he was successfullytreated with tolvaptan.

The man presented due to a fall followed by a convulsiveepisode with tonic-clonic seizures lasting 10 minutes. Hisfamily reported that he had been unstable when walking,irritable, disorientated and emotionally labile during thelast 15 days. He had a history of frontal dementia, anddepressive syndrome in the third week of treatment withcitalopram [dosage and route not stated]. Based on sodiumlevels, and plasma and urine osmolarity findings, SIADHwas diagnosed.

Citalopram, suspected as the causative agent, waswithdrawn. The man’s symptoms and hyponatraemiapersisted despite water restriction and a hypertonic sodiumchloride infusion was started. Attempts to withdraw theinfusion over 3 weeks failed and tolvaptan 15 mg/day wasintroduced, with normalisation of his sodium levels.Treatment was withdrawn and he remained asymptomaticand normonatraemic 4 months after discharge.Pinal-Fernandez I, et al. Tolvaptan in antidiuretic hormone secretion syndromesecondary to treatment with citalopram. Revista Clinica Espanola 211: 491-2, No.9, Oct 2011 [Spanish; summarised from a translation] - Spain 803071344

1

Reactions 2 Jun 2012 No. 14040114-9954/10/1404-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved